Fresenius Medical Care Dirección
Dirección controles de criterios 1/4
El CEO de Fresenius Medical Care's es Helen Giza , nombrado en Nov 2019, tiene una permanencia de 4.42 años. compensación anual total es €5.53M, compuesta por 30.1% salario y 69.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.005% de las acciones de la empresa, por valor de €535.26K. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 0.3 años, respectivamente.
Información clave
Helen Giza
Chief Executive Officer (CEO)
€5.5m
Compensación total
| Porcentaje del salario del CEO | 30.1% |
| Permanencia del CEO | 4.6yrs |
| Participación del CEO | 0.005% |
| Permanencia media de la dirección | 1.5yrs |
| Promedio de permanencia en la Junta Directiva | less than a year |
Actualizaciones recientes de la dirección
Recent updates
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E
May 30
Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year
May 10Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19
Apr 26Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 29Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19
Mar 14Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19
Feb 23When Should You Buy Fresenius Medical Care AG (ETR:FME)?
Feb 22Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings
Feb 03Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital
Jan 16Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?
Dec 29Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Nov 21Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal
Oct 16Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?
Sep 28Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Aug 21An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued
Jul 23Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture
Jul 09These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively
Jun 25What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?
May 07Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?
Apr 23We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt
Mar 24Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?
Feb 03Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?
Jan 19Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively
Jan 04Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt
Dec 17Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think
Nov 08Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | €484m |
| Dec 31 2023 | €6m | €2m | €499m |
| Sep 30 2023 | n/a | n/a | €450m |
| Jun 30 2023 | n/a | n/a | €596m |
| Mar 31 2023 | n/a | n/a | €602m |
| Dec 31 2022 | €3m | €1m | €673m |
| Sep 30 2022 | n/a | n/a | €763m |
| Jun 30 2022 | n/a | n/a | €806m |
| Mar 31 2022 | n/a | n/a | €878m |
| Dec 31 2021 | €2m | €855k | €969m |
| Sep 30 2021 | n/a | n/a | €918m |
| Jun 30 2021 | n/a | n/a | €998m |
| Mar 31 2021 | n/a | n/a | €1b |
| Dec 31 2020 | €2m | €855k | €1b |
| Sep 30 2020 | n/a | n/a | €1b |
| Jun 30 2020 | n/a | n/a | €1b |
| Mar 31 2020 | n/a | n/a | €1b |
| Dec 31 2019 | €2m | €108k | €1b |
Compensación vs. Mercado: La compensación total ($USD5.89M) de Helen está en línea con el promedio de empresas de tamaño similar en el mercado German ($USD5.59M).
Compensación vs. Ingresos: La compensación de Helen ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.
CEO
Helen Giza (56 yo)
4.6yrs
Permanencia
€5,528,000
Compensación
Ms. Helen Giza is Chief Executive Officer and Chair of the Management Board of Fresenius Medical Care Management AG, General Partner of Fresenius Medical Care AG & Co. KGAA from December 6, 2022. She serve...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chair of Management Board & CEO | 4.6yrs | €5.53m | 0.0047% € 545.8k | |
| CFO & Member of the Management Board | less than a year | €887.00k | sin datos | |
| Global Chief Medical Officer & Member of Management Board | 4.4yrs | €3.13m | 0.0062% € 720.8k | |
| CEO of Care Enablement & Member of Management Board | 2.4yrs | €3.71m | 0.0039% € 451.4k | |
| CEO of Care Delivery & Member of Management Board | less than a year | sin datos | sin datos | |
| Executive VP and Head of Investor Relations | no data | sin datos | sin datos | |
| Global Head of Legal | no data | sin datos | sin datos | |
| Senior Vice President of Corporate Communications & Governmental Affairs | no data | sin datos | sin datos | |
| Senior Vice President of Research & Development | no data | sin datos | sin datos | |
| Senior Vice President of Manufacturing and Supply Chain Operations | no data | sin datos | sin datos | |
| Senior Vice President - Quality Management International | no data | sin datos | sin datos | |
| Executive Vice President of Western Europe & Nephrocare Coordination EMEALA | no data | sin datos | sin datos |
1.5yrs
Permanencia media
56.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de FME no se considera experimentado ( 1.5 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Independent Member of Supervisory Board | less than a year | €20.00k | sin datos | |
| Chairman of the Supervisory Board | less than a year | €444.00k | sin datos | |
| Independent Member of Supervisory Board | 8.1yrs | €230.00k | sin datos | |
| Independent Member of Supervisory Board | less than a year | €21.00k | sin datos | |
| Independent Member of Supervisory Board | 3.1yrs | €151.00k | sin datos | |
| Employee Representative Deputy Chairwoman of the Supervisory Board | less than a year | sin datos | sin datos | |
| Member of Supervisory Board | less than a year | €158.00k | sin datos | |
| Employee Representative Member of Supervisory Board | less than a year | sin datos | sin datos | |
| Employee Representative Member of the Supervisory Board | less than a year | sin datos | sin datos | |
| Employee Representative Member of the Supervisory Board | less than a year | sin datos | sin datos | |
| Employee representatives Member of the Supervisory Board | less than a year | sin datos | sin datos | |
| Employee representatives Member of the Supervisory Board | less than a year | sin datos | sin datos |
0.5yrs
Permanencia media
56yo
Promedio de edad
Junta con experiencia: La junta directiva de FME no se considera experimentada (0.3 años de permanencia promedio), lo que sugiere una nueva junta directiva.